NCT03580005View on ClinicalTrials.gov

A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2018

Primary Completion Date

October 12, 2021

Study Completion Date

October 12, 2021

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)Attention Deficit Hyperactivity Disorder
Interventions
DRUG

methylphenidate HCl ERCT

methylphenidate HCl ERCT

DRUG

Placebo

Placebo to Match Quillichew ERCT

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03580005 - A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. | Biotech Hunter | Biotech Hunter